Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (101-110 of 213) with videos related to

Pageof 22
Sort By:
Pancreas|February 13, 2014
Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionEric S Engelman, Roberto Leon-Ferre, Boris G Naraev, et al.
Pancreas|May 2, 2025
Pancreatic Neuroendocrine Tumors-A Descriptive Study of the Presenting Features in a 20-Year Surgical Resection Cohort at a Tertiary InstitutionJassimran Singh, Hallbera Gudmundsdottir, Thorvardur R Halfdanarson, et al.
Annals of Surgical Oncology|April 28, 2024
Presacral Neuroendocrine Neoplasms: A Multi-site Review of Surgical OutcomesTommaso Violante, Brenda Murphy, Davide Ferrari, et al.
Journal of the American Board of Family Medicine : JABFM|July 9, 2015
Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer ScreeningJennifer A Schlichting, Michelle A Mengeling, Nader M Makki, et al.
Journal of Oncology Practice|June 18, 2015
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance ConsortiumMary E Charlton, Karyn B Stitzenberg, Chi Lin, et al.
Journal of Community Health|February 7, 2014
Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing programJennifer A Schlichting, Michelle A Mengeling, Nader M Makki, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 15, 2015
Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare DataMary E Charlton, Jennifer E Hrabe, Kara B Wright, et al.
Clinical Colorectal Cancer|February 8, 2021
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment OptionsBenjamin E Ueberroth, Alex J Liu, Jason S Starr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2018
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer DatabaseDevalkumar J Rajyaguru, Andrew J Borgert, Angela L Smith, et al.
The Oncologist|January 26, 2021
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine TumorsAlex J Liu, Benjamin E Ueberroth, Patrick W McGarrah, et al.
Pageof 22

Showing results (101-110 of 213) with videos related to

Sort By:
Pageof 22
Pancreas|February 13, 2014
Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionEric S Engelman, Roberto Leon-Ferre, Boris G Naraev, et al.
Pancreas|May 2, 2025
Pancreatic Neuroendocrine Tumors-A Descriptive Study of the Presenting Features in a 20-Year Surgical Resection Cohort at a Tertiary InstitutionJassimran Singh, Hallbera Gudmundsdottir, Thorvardur R Halfdanarson, et al.
Annals of Surgical Oncology|April 28, 2024
Presacral Neuroendocrine Neoplasms: A Multi-site Review of Surgical OutcomesTommaso Violante, Brenda Murphy, Davide Ferrari, et al.
Journal of the American Board of Family Medicine : JABFM|July 9, 2015
Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer ScreeningJennifer A Schlichting, Michelle A Mengeling, Nader M Makki, et al.
Journal of Oncology Practice|June 18, 2015
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance ConsortiumMary E Charlton, Karyn B Stitzenberg, Chi Lin, et al.
Journal of Community Health|February 7, 2014
Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing programJennifer A Schlichting, Michelle A Mengeling, Nader M Makki, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 15, 2015
Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare DataMary E Charlton, Jennifer E Hrabe, Kara B Wright, et al.
Clinical Colorectal Cancer|February 8, 2021
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment OptionsBenjamin E Ueberroth, Alex J Liu, Jason S Starr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2018
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer DatabaseDevalkumar J Rajyaguru, Andrew J Borgert, Angela L Smith, et al.
The Oncologist|January 26, 2021
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine TumorsAlex J Liu, Benjamin E Ueberroth, Patrick W McGarrah, et al.
Pageof 22